Precipio, Inc. (PRPO) Stock Analysis & Investment Frameworks
Precipio, Inc. (PRPO) stock analysis on Invetso. Review Precipio, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Precipio, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
Precipio, Inc. Key Financial Metrics
- Market Cap: $33.28M
- Revenue: $24.05M
- ROE: -8.49%
- ROIC: -8.43%
- Dividend Yield: N/A
About Precipio, Inc.
Precipio, Inc., based in New Haven, Connecticut, functions as a healthcare solutions provider within the United States. The company delivers a range of diagnostic products, reagents, and services, specifically offering diagnostic testing for blood cancers. Its advanced offerings include IV-Cell, a unique cell culture media capable of simultaneously growing four types of hematopoietic cell lineages, and HemeScreen, a comprehensive collection of genetic diagnostic panels. Precipio also develops COVID-19 antibody tests. A notable proprietary innovation is ICE-COLD PCR, a patented technology designed to boost the sensitivity of molecular tests, with kits for this technology also sold to biopharmaceutical customers. Additionally, Precipio, Inc. collaborates with academic institutions dedicated to cancer research, diagnosis, and therapy.
Precipio, Inc. Investment Frameworks
Invetso analyzes Precipio, Inc. (PRPO) across the following frameworks:
- Precipio, Inc. 10Y Growth Potential
- Precipio, Inc. Scenario Analysis
- Precipio, Inc. Risks & Opportunities
- Precipio, Inc. Economic Moat
- Precipio, Inc. Business Model
- Precipio, Inc. Management
- Precipio, Inc. SWOT Analysis
- Precipio, Inc. Porter's 5 Forces
- Precipio, Inc. PESTLE Analysis
- Precipio, Inc. ESG Analysis